JP2010506844A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506844A5
JP2010506844A5 JP2009532504A JP2009532504A JP2010506844A5 JP 2010506844 A5 JP2010506844 A5 JP 2010506844A5 JP 2009532504 A JP2009532504 A JP 2009532504A JP 2009532504 A JP2009532504 A JP 2009532504A JP 2010506844 A5 JP2010506844 A5 JP 2010506844A5
Authority
JP
Japan
Prior art keywords
leu
arg
val
glu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009532504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506844A (ja
JP5200027B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/080367 external-priority patent/WO2008048784A1/en
Publication of JP2010506844A publication Critical patent/JP2010506844A/ja
Publication of JP2010506844A5 publication Critical patent/JP2010506844A5/ja
Application granted granted Critical
Publication of JP5200027B2 publication Critical patent/JP5200027B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009532504A 2006-10-13 2007-10-04 Pth受容体モジュレーターとしてのペグ化pthおよびその使用 Expired - Fee Related JP5200027B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82938306P 2006-10-13 2006-10-13
US60/829,383 2006-10-13
PCT/US2007/080367 WO2008048784A1 (en) 2006-10-13 2007-10-04 Pegylated pth as pth receptor modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2010506844A JP2010506844A (ja) 2010-03-04
JP2010506844A5 true JP2010506844A5 (cg-RX-API-DMAC7.html) 2010-10-07
JP5200027B2 JP5200027B2 (ja) 2013-05-15

Family

ID=42828673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009532504A Expired - Fee Related JP5200027B2 (ja) 2006-10-13 2007-10-04 Pth受容体モジュレーターとしてのペグ化pthおよびその使用

Country Status (16)

Country Link
US (1) US7820179B2 (cg-RX-API-DMAC7.html)
EP (1) EP2084183B1 (cg-RX-API-DMAC7.html)
JP (1) JP5200027B2 (cg-RX-API-DMAC7.html)
KR (1) KR101108354B1 (cg-RX-API-DMAC7.html)
CN (1) CN101522709B (cg-RX-API-DMAC7.html)
AT (1) ATE469173T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007313001B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0719885B8 (cg-RX-API-DMAC7.html)
CA (1) CA2672907C (cg-RX-API-DMAC7.html)
DK (1) DK2084183T3 (cg-RX-API-DMAC7.html)
EA (1) EA014696B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009003740A (cg-RX-API-DMAC7.html)
NO (1) NO341986B1 (cg-RX-API-DMAC7.html)
PL (1) PL2084183T3 (cg-RX-API-DMAC7.html)
SI (1) SI2084183T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008048784A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2964463C (en) 2014-10-22 2024-02-13 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
MA45277A (fr) * 2016-03-01 2019-01-09 Ascendis Pharma Bone Diseases As Promédicaments de pth
SMT202500059T1 (it) 2016-09-29 2025-03-12 Ascendis Pharma Bone Diseases As Composti pth a rilascio controllato
CA3037447A1 (en) * 2016-09-29 2018-04-05 Ascendis Pharma Bone Diseases A/S Pth compounds with low peak-to-trough ratios
PL3518960T3 (pl) 2016-09-29 2023-12-27 Ascendis Pharma Bone Diseases A/S Schemat dawkowania związku pth o kontrolowanym uwalnianiu
WO2019232283A1 (en) * 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
CN113423383A (zh) 2019-02-11 2021-09-21 阿森迪斯药物骨疾病股份有限公司 Pth缀合物的液体药物制剂
AU2023353057A1 (en) 2022-09-30 2025-05-01 Extend Biosciences, Inc. Long-acting parathyroid hormone

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
JPS6360940A (ja) 1986-09-01 1988-03-17 Toyo Jozo Co Ltd 白内障の予防または治療剤
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
JPH05271279A (ja) * 1991-08-07 1993-10-19 Takeda Chem Ind Ltd ヒト副甲状腺ホルモンムテインおよびその製造法
US5814603A (en) 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
SI9720057A (sl) 1996-08-02 1999-12-31 National Research Council Of Canada Paratiroidni hormonski analogi za zdravljenje osteoporoze
HUP0003349A3 (en) * 1997-05-14 2001-12-28 Aventis Pharmaceuticals Inc Co Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
EP1030658A1 (en) * 1997-10-14 2000-08-30 Eli Lilly And Company Method of building and maintaining bone
CA2321026A1 (en) 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
EA200001071A1 (ru) 1998-04-15 2001-08-27 Авентис Фармасьютикалз Продактс Инк. Способ получения полимер-связанных циклических пептидов
HUP0300891A2 (hu) 1998-05-05 2003-07-28 Beth Israel Deaconess Medical Center, Inc. PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására
US6316410B1 (en) * 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US7022815B1 (en) * 1999-09-29 2006-04-04 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
WO2001023521A2 (en) 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EP1439854B1 (en) * 2001-07-23 2016-12-14 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
JPWO2003064462A1 (ja) * 2002-02-01 2005-05-26 中外製薬株式会社 Peg結合pth又はpeg結合pth誘導体
US7799757B2 (en) * 2002-06-13 2010-09-21 Michael Chorev Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
TW533925U (en) * 2002-09-26 2003-05-21 Lee Yeong Ind Co Ltd Improvement of speed-changing transmission mechanism for cutting tools of drill sharpening machine
WO2004060386A1 (en) 2002-11-01 2004-07-22 Amgen, Inc. Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
MXPA05007151A (es) 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Polimeros terminados en maleimida hidroliticamente estables.
JPWO2004084918A1 (ja) * 2003-03-25 2006-06-29 積水化学工業株式会社 皮膚止痒外用組成物
US20040220094A1 (en) * 2003-05-01 2004-11-04 Skinner Keith K. Inverse agonist and agonist peptides that stimulate/inhibit hair growth
EP1758927A4 (en) 2004-01-21 2008-09-17 Unigene Lab Inc PARATHYROID HORMONE AMIDE FRAGMENTS AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2010506844A5 (cg-RX-API-DMAC7.html)
CN1137898C (zh) 甲状旁腺素的类似物
JP2009510025A5 (cg-RX-API-DMAC7.html)
RU2506274C2 (ru) Способы скрининга с применением g-белок сопряженных рецепторов и родственных композиций
JP2011524420A5 (cg-RX-API-DMAC7.html)
JP2008529558A5 (cg-RX-API-DMAC7.html)
ES2324153T3 (es) Motivo de union a integrina que contiene peptidos y metodo para el tratamiento de enfermedades del esqueleto.
ES2310187T3 (es) Productos dentales que comprenden un peptido que potencia el crecimiento oseo.
Seguin et al. The earliest dental prosthesis in Celtic Gaul? The case of an Iron Age burial at Le Chêne, France
JP2012528887A5 (cg-RX-API-DMAC7.html)
WO2013054329A1 (en) Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
US20090074680A1 (en) Statherin peptide and use in medicine
JP2003516417A5 (cg-RX-API-DMAC7.html)
JP5047323B2 (ja) 生理活性ペプチド及びこれを含有する薬剤
JP2012501351A5 (cg-RX-API-DMAC7.html)
JP2012529444A5 (cg-RX-API-DMAC7.html)
JP5529014B2 (ja) 部位特異的なペグ化をされた直鎖状のサケカルシトニン類似体
JP2009507077A5 (cg-RX-API-DMAC7.html)
JP2020506237A (ja) 骨障害の改善のための化合物、組成物、及びその使用
EP1619204A1 (en) PTH-like peptides
JP2014515751A5 (cg-RX-API-DMAC7.html)
Desai et al. All ceramic inlay: a case report
CN100336827C (zh) 中国南海信号芋螺神经毒素及其编码序列和用途
AU2015202418B2 (en) Designer osteogenic proteins
Rajendra et al. Ellis-van Creveld syndrome